All filters
Slidesets
Abstract: Risk factors for RSV severity in immunocompetent and immunocompromised adults presenting in an emergency department (#103) | Slim Fourati
Presented at:
RespiDART 2018
Slidesets
Abstract: Non-targeted diagnosis of multiple viral infections by means of shotgun metagenomic using deep sequencing (#104) | Slim Fourati, PhD
Presented at:
RespiDART 2018
Slidesets
Plenary Lecture: Opportunities and Challenges for a Broadly Protective Influenza Vaccine | Gary Nabel, MD
Presented at:
RespiDART 2018
Slidesets
RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD
Presented at:
RespiDART 2018
Slidesets
Cocrystal Pharma: Influenza drug pipeline design | Sam Lee, PhD
Presented at:
RespiDART 2018
Slidesets
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Pharmacology and new modes of delivery | David Back, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Videos
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Videos
3D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhD
Presented at:
RespiDART 2018
Videos
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Videos
RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD
Presented at:
RespiDART 2018
Meeting
RespiDART 2018
Videos
Polypharmacy in an aging population and implications for antiretroviral therapy | Charles Flexner, MD
Presented at:
HIV DART and Emerging Viruses 2018
Videos
A post-transcriptional feedback mechanism for noise suppression and fate stabilization | Leor Weinberger, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Videos
Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhD
Presented at:
HIV DART and Emerging Viruses 2018